Briefs
Biostatistics News
Category
Biostatistics News

White matter plays a complex role in brain health

July 2, 2021
New research from UNC-Chapel Hill suggests that some diseases affecting white matter may be associated with structural and genetic abnormalities in the brain, which sheds further light on the complex genetic relationship between white matter, brain disease and mental health.

Ancestral diversity affects biomarkers of kidney function, study finds

June 3, 2021
DNA methylation (DNAm) is known to be linked with kidney function, but earlier research had not revealed whether human diversity affects this association. Now, a study has reported several new trans-ethnic and ethnic-specific DNAm associations with kidney function. This is an important finding for public health because it informs future steps to understand and address epigenomic diversity.

Taking more steps daily may lead to a longer life

May 20, 2021
Taking more steps per day, either all at once or in shorter spurts, may help you live longer, according to preliminary research to be presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021.

Obesity may slow progress against cancer deaths 

May 12, 2021
Cancer death rates have fallen dramatically in the United States. Factor in obesity, however — as Gillings School researchers did, and the picture changes. A study published May 10 in JAMA Network Open reports that obesity-related cancer deaths are improving, but at a slowing pace.

Findings from Kenya: Male circumcision reduces HPV infections

May 10, 2021
It’s well-established that male circumcision reduces the risk of human immunodeficiency virus (HIV) infection in men. A recent study from Kenya, published in Cancer Epidemiology, Biomarkers & Prevention, finds that male circumcision also reduces men’s risk of infection with human papillomavirus (HPV).

Researchers develop method for evaluating long-term COVID-19 vaccine efficacy

April 27, 2021
The large-scale deployment of effective vaccines is globally recognized as the best way to end the COVID-19 pandemic. However, the high efficacy reported for vaccines currently in use — like Pfizer and Moderna — is based on an average follow-up time of only about two months after the second dose. The question remains: Will people need booster vaccinations?